Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the ...

The next-gen immunotherapies market is evolving with biotech advances, rising cancer cases, new therapies, funding, and ...

SYDNEY, AU / ACCESS Newswire / May 27, 2025 / Dateline Resources Limited (ASX:DTR)(OTC PINK:DTREF), a leading Australian ...